Find out about the latest news on Thorasys and our respiratory function monitoring products like the tremoflo.

Thorasys is pleased to announce the signature of a worldwide exclusive licensing agreement for the acquisition of REOM technology from Spiro-tech Inc.

Thorasys wants to help the early detection of exacerbation in patients with respiratory diseases including COVID-19.

The global pandemic of COVID-19 is growing and affects all aspects of the society.

It is with enthusiasm that we are making the tremoflo N-100 available for research purpose for the study of respiratory function in toddlers, especially from their very first days.

THORASYS Chairman Marcel Larochelle is pleased to announce the appointment of Mr. Yvan Beaudoin as President and CEO of THORASYS Inc. effective September 1, 2017.